Matthias Sury
About Matthias Sury
Matthias Sury serves as the Manager of Method Development LC-MS at Celerion in Lincoln, Nebraska, where he has worked since 2018. He holds advanced degrees in Molecular Biology and Philosophy from the University of Bern and has extensive experience in neuroscience and quantitative proteomics.
Work at Celerion
Matthias Sury has served as the Manager of Method Development for Liquid Chromatography-Mass Spectrometry (LC-MS) at Celerion since 2018. In this role, he is responsible for overseeing the development and optimization of analytical methods for small molecules and peptides. His work focuses on enhancing the efficiency and accuracy of LC-MS techniques, contributing to the company's capabilities in bioanalytical services. Celerion is located in Lincoln, Nebraska, where Sury has been a key figure in advancing the organization's research and development efforts.
Previous Experience at Swiss Bioanalytics
Prior to his tenure at Celerion, Matthias Sury worked as a Study Director at Swiss Bioanalytics from 2013 to 2018. During his five years in this position, he managed various bioanalytical studies, ensuring compliance with regulatory standards and scientific rigor. His role involved coordinating research projects and collaborating with multidisciplinary teams to deliver high-quality results in the field of bioanalysis.
Education and Expertise
Matthias Sury obtained his Doctorate in Philosophy (Ph.D.) from the University of Bern, where he studied Molecular Biology and Philosophy from 2004 to 2008. He also holds a Master's degree in Biology, with a focus on Microbiology and Immunology, earned from the same institution between 1999 and 2004. His academic background provides a strong foundation for his extensive research experience in neuroscience, cellular signaling, and host-pathogen interactions, as well as his expertise in quantitative proteomics.
Research Specialization
Matthias Sury specializes in the development of methods for the analysis of small molecules and peptides through liquid chromatography-coupled mass spectrometry (LC-MS). His expertise encompasses both in vitro and in vivo quantitative proteomics, allowing for detailed analysis and characterization of biological samples. This specialization is critical for advancing research in various scientific fields, including pharmacology and biochemistry.